Linda de Bruin

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S

Tom J. Harryvan, Marten Visser, Linda de Bruin et al. · Journal for ImmunoTherapy of Cancer · 2022 · 38 citations · Full text

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study

Els M.E. Verdegaal, Monique K. van der Kooij, Marten Visser et al. · Journal for ImmunoTherapy of Cancer · 2020 · 26 citations · Full text

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

Els M.E. Verdegaal, Saskia J. Santegoets, Marij J.P. Welters et al. · Journal for ImmunoTherapy of Cancer · 2023 · 25 citations · Full text

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial

Monique K. van der Kooij, Els M.E. Verdegaal, Marten Visser et al. · BMJ Open · 2020 · 11 citations · Full text